Extending organizational schema for causal effects

Epidemiology

Volumn 25, Issue 1, 2014, Pages 98-102

  Hoggatt, Katherine J ^a,b   Greenland, Sander ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CAUSAL ATTRIBUTION; CLASSIFICATION; CLINICAL PRACTICE; HEALTH CARE POLICY; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; METHODOLOGY; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; EPIDEMIOLOGY; NOTE; RISK;

CAUSALITY; EPIDEMIOLOGIC STUDIES; HUMANS; RISK;

EID: 84890107266     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000023     Document Type: Review

References (42)

1. Gatto NM, Campbell UB, Schwartz S. An organizational schema for epidemiologic causal effects. Epidemiology. 2014;25:88-97
2. Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology. 2003;14:680-686
3. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163:262-270
4. Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci. 2010;25:1-21
5. M organ SL, Winship C. Counterfactuals and Causal Inference: Methods and Principles for Social Research (Analytical Methods for Social Research). New York: Cambridge University Press; 2007
6. Pearl J. Causality: Models, Reasoning, and Inference. 2nd ed. New York: Cambridge University Press; 2009
7. Pearl J. On the consistency rule in causal inference: Axiom, definition, assumption, or theorem? Epidemiology. 2010;21:872-875
8. Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol. 1987;125:761-768
9. M artens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Systematic differences in treatment effect estimates between propensity score methods and logistic regression. Int J Epidemiol. 2008;37:1142-1147
10. Imbens G. Nonparametric estimation of average treatment effects under exogeneity: A review. Rev Econ Stat. 2004;86:4-30
11. Imai K, King G, Stuart EA. Misunderstandings between experimentalists and observationalists about causal inference. J Roy Stat Soc. 2008;171:481-502
12. Greenland S. Introduction to regression analysis. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008:418-455
13. Vansteelandt S, Keiding N. Invited commentary: G-computation-lost in translation? Am J Epidemiol. 2011;173:739-742
14. Greenland S, Frerichs RR. On measures and models for the effectiveness of vaccines and vaccination programmes. Int J Epidemiol. 1988;17:456-463
15. R obins J, Greenland S. Estimability and estimation of expected years of life lost due to a hazardous exposure. Stat Med. 1991;10:79-93
16. Boshuizen HC, Greenland S. Average age at first occurrence as an alternative occurrence parameter in epidemiology. Int J Epidemiol. 1997;26:867-872
17. Greenland S, Robins JM. Epidemiology, justice, and the probability of causation. Jurimetrics. 2000;40:321
18. Samuels ML. Matching and design efficiency in epidemiological studies. Biometrika. 1981;68:577-588
19. Greenland S, Robins JM, Pearl J. Confounding and collapsibility in causal inference. Stat Sci. 1999;14:29-46
20. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology. 1996;7:498-501
21. A ustin PC, Grootendorst P, Normand SLT, Anderson GM. Authors' reply. Stat Med. 2007;26:3210-3212
22. Shpitser I, Pearl J. Effects of treatment on the treated: Identification and generalization. In: Bilmes J, Ng AY, eds. Proceedings of the Twenty-Fifth Conference on Uncertainty in Artificial Intelligence. Arlington, VA: AUAI Press; 2009;514-521
23. R idgeway G, MacDonald JM. Doubly robust internal benchmarking and false discovery rates for detecting racial bias in police stops. J Am Stat Assoc. 2009;104:661-668
24. Stürmer T, Rothman KJ, Glynn RJ. Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf. 2006;15:698-709
25. Greenland S, Maldonado G. The interpretation of multiplicative-model parameters as standardized parameters. Stat Med. 1994;13:989-999
26. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-664
27. Westreich D, Lessler J, Funk MJ. Propensity score estimation: Neural networks, support vector machines, decision trees (CART) , and meta-classifiers as alternatives to logistic regression. J Clin Epidemiol. 2010;63:826-833
28. Lee BK, Lessler J, Stuart EA. Weight trimming and propensity score weighting. PLoS One. 2011;6:e18174
29. A ngrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91:444-455
30. Joffe M. Principal stratification and attribution prohibition: Good ideas taken too far. Int J Biostat. 2011;7:Article 35
31. VanderWeele TJ. Principal stratification-uses and limitations. Int J Biostat. 2011;7:Article 28
32. Hernán MA, Robins JM. Instruments for causal inference: An epidemiologist's dream? Epidemiology. 2006;17:360-372
33. Pearl J. Principal stratification-A goal or a tool? Int J Biostat. 2011;7:20
34. Sjolander A. Reaction to Pearl's critique of principal stratification. Int J Biostat. 2011;7:1-5
35. Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. Am J Epidemiol. 2010;172:107-115
36. Bareinboim E, Pearl J. Meta-Transportability of causal effects: A formal approach. Proceedings of the Sixteenth International Conference on Artificial Intelligence and Statistics (AISTAT S 2013); 2013; Scottsdale, AZ.
37. Hartman E, Grieve R, Ramsahai R, Sekhon JS. From SATE to PATT : Combining Experimental with Observational Studies to Estimate Population Treatment Effects. Working Paper. 2013;1-32
38. Pressler TR, Kaizar EE. The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias. Stat Med. 2013;32:3552-3568
39. Halloran ME, Struchiner CJ. Causal inference in infectious diseases. Epidemiology. 1995;6:142-151
40. Hudgens MG, Halloran ME. Toward Causal Inference With Interference. J Am Stat Assoc. 2008;103:832-842
41. R osenbaum PR. Interference between units in randomized experiments. J Am Statist Assoc. 2007;102:191-200
42. T chetgen EJ, VanderWeele TJ. On causal inference in the presence of interference. Stat Methods Med Res. 2012;21:55-75